Jan van der Greef
Jan van der Greef is Professor of Analytical Biosciences at Leiden University within the Leiden/Amsterdam Center for Drug Research. Further, he is Scientific Director of Systems Biology Research at TNO, Netherlands Organization for Applied Scientific Research. The emphasis of TNO Pharma is on novel instrumental developments in synergy with biological/biomedical expertise. Jan van der Greef is also co-founder of BG Medicine Inc, the first Systems Biology company, one of the initiators of the Center for Medical Systems Biology, a genomics center of excellence supported by the Netherlands Genomics Initiative, and co-founder of Kiadis, a drug discovery company focusing on high resolution screening platforms for natural products and orphan targets.Jan van der Greef has published over 250 papers in international journals and supervised more than 22 PhD thesis projects. He received an award for major contributions in drug analysis by the Belgium Society of Pharmaceutical Sciences in 1998, became honorary doctor at Ghent University in 2000 and received the AAPS Pharmaceutical Scientist award as one of the authors of the best analytical paper in 2002. His current research interest includes the development of systems biology with novel proteomics technologies, metabolomics fingerprinting and biostatistics, applied to the characterization of complex biological systems. He is considered a pioneer in the field of liquid chromatography coupled to mass spectrometry (LCMS), bodyfluid profiling and pattern recognition, and among the first to develop single cell profiling by mass spectrometry.
